Details for Patent: 10,537,585
Which drugs does patent 10,537,585 protect, and when does it expire?
Patent 10,537,585 protects HEMADY and is included in one NDA.
This patent has one patent family member in one country.
Summary for Patent: 10,537,585
| Title: | Compositions comprising dexamethasone |
| Abstract: | A pharmaceutical composition useful for the treatment of multiple myeloma in combination with an anti-cancer drug is provided. The pharmaceutical composition includes high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof. |
| Inventor(s): | Caterina KREYENBORG, Elisabeth MEIMBERG, Corinna TISSEN, Karl-Heinz BANNEFELD, Tomer Gold |
| Assignee: | Dexcel Pharma Technologies Ltd |
| Application Number: | US15/845,232 |
|
Patent Claim Types: see list of patent claims | Compound; Dosage form; |
Drugs Protected by US Patent 10,537,585
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dexcel | HEMADY | dexamethasone | TABLET;ORAL | 211379-001 | Oct 3, 2019 | RX | Yes | Yes | 10,537,585 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,537,585
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| World Intellectual Property Organization (WIPO) | 2019123453 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
